Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2025 09:01 ET | Source: PharmAla Biotech

PharmAla Completes Shipment of LaNeo™ MDMA to UCLA for Schizophrenia Study

PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial
October 28, 2024 05:51 ET | Source: SAI LIFE SCIENCES LIMITED

Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities

HYDERABAD, India, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has...
August 09, 2024 18:18 ET | Source: PharmAla Biotech

PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002

PharmAla expresses disappointment in USFDA's decision to request a third Phase 3 for MDMA and announces the patent granting for a safer MDMA analog variant
November 02, 2022 09:00 ET | Source: PharmAla Biotech

PharmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA

VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug...
January 27, 2020 16:05 ET | Source: Jubilant Pharma

Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®

YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...
August 27, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Announces Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...